Analysis of TNFAIP3, IRAK1, and TLR4 Gene Polymorphisms in Patients With Rheumatoid Arthritis
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 12.02.2026. Verfasst von Zhenboyang Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Arthritis, Rheumatoid, Toll-Like Receptor 4, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Technology Department in Sichuan Province.
Abstract (Originalsprache)
Objective
Rheumatoid arthritis (RA) arises from a complex interplay of polygenic susceptibility, epigenetic factors, and environmental modifiers. This study investigated the correlation between RA and Tumor necrosis factor α‐induced protein 3 (TNFAIP3), Interleukin‐1 receptor‐associated kinase 1 (IRAK1), and Toll‐like receptor 4 (TLR4) gene polymorphisms.
Methods
A sample of 308 RA cases and 310 matched controls was included. Genotyping of the TNFAIP3, IRAK1, and TLR4 was performed via mass spectrometry.
Results
Compared to healthy controls, individuals carrying the rs1059703 A allele (odds ratio (OR) = 0.640, 95% confidence interval (CI): 0.458–0.895, p = 0.009) of IRAK1, individuals carrying the rs5029930 C allele (OR = 0.469, 95% CI: 0.298–0.739, p = 0.001), and AC genotype (OR = 0.427, 95% CI: 0.255–0.716, p = 0.001) of TNFAIP3 had a lower RA risk. Individuals carrying the rs5029939 C allele (OR = 2.401, 95% CI: 1.436–4.017, p = 0.001) of TNFAIP3, individuals carrying the rs7873784 C allele (OR = 1.549, 95% CI: 1.101–2.179, p = 0.012), and CG genotype (OR = 1.489, 95% CI: 1.011–2.193, p = 0.043) of TLR4 had a higher RA risk.
Conclusion
In summary, the TNFAIP3, IRAK1, and TLR4 gene polymorphisms are associated with RA susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.
- Department of Rheumatology and Immunology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, China.
- Department of Rheumatology and Immunology, The Second People's Hospital of Meishan City, Meishan, Sichuan, China.
- Stem Cell Immunity and Regeneration Key Laboratory of Luzhou, P.R. China.
ORCID-Profile: Jie Chen
Förderung
- Project of Technology Department in Sichuan Province
Zitieren
APA
Tang, Z., Peng, L., Zhao, Z., Zhou, X., Ling, X., Huang, C., Wu, J., Wang, P., & Chen, J. (2026). Analysis of TNFAIP3, IRAK1, and TLR4 Gene Polymorphisms in Patients With Rheumatoid Arthritis. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70344
Vancouver
Tang Z, Peng L, Zhao Z, Zhou X, Ling X, Huang C, et al. Analysis of TNFAIP3, IRAK1, and TLR4 Gene Polymorphisms in Patients With Rheumatoid Arthritis. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70344
BibTeX
@article{Tang2026,
author = {Tang, Zhenboyang and Peng, Lihui and Zhao, Zixia and Zhou, Xiping and Ling, Xiru and Huang, Chunyan and Wu, Jiqiang and Wang, Ping and Chen, Jie},
title = {Analysis of TNFAIP3, IRAK1, and TLR4 Gene Polymorphisms in Patients With Rheumatoid Arthritis},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70344}
}
EUVIMED